These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696 [TBL] [Abstract][Full Text] [Related]
25. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687 [TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Ross DA; Wilson GD Br J Surg; 1997 Jun; 84(6):803-7. PubMed ID: 9189093 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. Tchernev G; Orfanos CE J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609 [TBL] [Abstract][Full Text] [Related]
28. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma. Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539 [TBL] [Abstract][Full Text] [Related]
30. Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma. Vuoristo M; Vihinen P; Vlaykova T; Nylund C; Heino J; Pyrhönen S Melanoma Res; 2007 Aug; 17(4):215-23. PubMed ID: 17625451 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of beta1 integrin expression in metastatic melanoma. Vihinen P; Nikkola J; Vlaykova T; Hahka-Kemppinen M; Talve L; Heino J; Pyrhönen S Melanoma Res; 2000 Jun; 10(3):243-51. PubMed ID: 10890378 [TBL] [Abstract][Full Text] [Related]
32. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922 [TBL] [Abstract][Full Text] [Related]
33. Novel role for RGS1 in melanoma progression. Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492 [TBL] [Abstract][Full Text] [Related]
34. Tenascin-C in primary malignant melanoma of the skin. Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480 [TBL] [Abstract][Full Text] [Related]
35. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620 [TBL] [Abstract][Full Text] [Related]
36. The prognostic importance of c-myc oncogene expression in head and neck melanoma. Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO Ann Plast Surg; 2001 Aug; 47(2):172-7. PubMed ID: 11506326 [TBL] [Abstract][Full Text] [Related]
37. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007 [TBL] [Abstract][Full Text] [Related]
38. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208 [TBL] [Abstract][Full Text] [Related]
39. PUMA expression is significantly reduced in human cutaneous melanomas. Karst AM; Dai DL; Martinka M; Li G Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057 [TBL] [Abstract][Full Text] [Related]
40. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. McKenna DB; Lee RJ; Prescott RJ; Doherty VR Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]